1. Stratification Risk and Monitoring of Patient by MRI
   Alice Brandão et al, 2018, Atlas of Deep Endometriosis CrossRef
2. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma
   AKANE TAKAYA et al, 2015, International Journal of Oncology CrossRef
3. Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
   HIROSHI KOBAYASHI et al, 2015, Oncology Letters CrossRef
4. The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma
   Umran Kucukgoz Gulec et al, 2015, Archives of Gynecology and Obstetrics CrossRef
5. Updates and emerging therapies for rare epithelial ovarian cancers: One size no longer fits all
   Reinou S. Groen et al, 2015, Gynecologic Oncology CrossRef
6. Tumor metabolism regulating chemosensitivity in ovarian cancer
   Chae Young Han et al, 2018, Genes & Cancer CrossRef
7. Napsin A, Hepatocyte Nuclear Factor-1-Beta (HNF-1β), Estrogen and Progesterone Receptors Expression in Arias-Stella Reaction
   Philip P.C. Ip et al, 2019, American Journal of Surgical Pathology CrossRef
8. Contemporary Treatment Strategies for Rare Epithelial Ovarian Cancers
   Jennifer E. Bergstrom et al, 2017, Current Obstetrics and Gynecology Reports CrossRef
9. L’endométriose est-elle une lésion pré-cancéreuse ? Perspectives et implications cliniques
   G. Chene et al, 2016, Gynécologie Obstétrique & Fertilité CrossRef
10. Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinoma
    Ryo Tamura et al, 2021, Gynecologic Oncology CrossRef
11. SWI/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models
    Yemin Wang et al, 2020, Annual Review of Pathology: Mechanisms of Disease CrossRef
12. Molecular pathogenesis of ovarian clear cell carcinoma
    Ioannis Gounaris et al, 2015, Future Oncology CrossRef
13. Altered Organelle Calcium Transport in Ovarian Physiology and Cancer
    Laura Caravia et al, 2020, Cancers CrossRef
14. Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma
    Tashbib Khan et al, 2020, Cancers CrossRef
15. Endometrioseassoziierte Tumorerkrankungen des Ovars
    D. Schmidt et al, 2014, Der Pathologe CrossRef
16. Updates on Rare Epithelial Ovarian Carcinoma
    J. Bergstrom et al, 2017, Translational Advances in Gynecologic Cancers CrossRef
17. Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
    Laura Feeney et al, 2020, World Journal of Clinical Oncology CrossRef
18. High glypican-3 expression characterizes a distinct subset of ovarian clear cell carcinomas in Canadian patients: an opportunity for targeted therapy
    Katharina Wiedemeyer et al, 2020, Human Pathology CrossRef
19. Distinguishing the progression of an endometrioma: Benign or malignant?
    Ercan Bastu et al, 2018, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef